Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Uncovering the mechanisms of osteoarthritis in human knee applying spatial transcriptomics

Project description

Novel spatial transcriptomics analysis in osteoarthritis studies

Osteoarthritis (OA) is a chronic musculoskeletal disorder associated with pain, morbidity and disability. Multi-omics analysis and single-cell RNA sequencing have identified involved cell clusters. The goal of the EU-funded SpatialArth project is to understand the molecular aetiopathogenesis and progression of OA using a novel, cutting-edge technique, spatial transcriptomics (ST). ST allows visualisation and quantitative analysis of the transcriptome with spatial near-single cell resolution in individual tissue sections. The combination of ST sequencing and protein expression data from cartilage and bone tissues will result in new knowledge on the molecular profile of the osteochondral unit and identify which cells are involved in the pathogenesis of OA.

Objective

Osteoarthritis (OA) is the most prevalent chronic musculoskeletal disorder causing pain, morbidity and disability, giving rise to enormous healthcare expenditures and loss of work. The exact triggers and pathogenesis of OA are still poorly understood. Currently, there are no measures to slow down the progression of OA. Bulk tissue-based multi-omics and small-scale single cell RNA-seq studies focussing on chondrocytes and synoviocytes have identified novel cell clusters, supporting the hypothesis that OA is a disease of the whole joint. However, one of the key relevant tissues (bone) have not yet been studied. In addition, approaches to date have employed lengthy live cell extraction approaches that affect the transcriptome pattern. Finally, the spatial dimension of molecular changes in the osteochondral unit has not been studied to date. This work will fill this fundamental gap in our understanding of the molecular aetiopathogenesis and progression of OA by employing a novel cutting-edge technique, spatial transcriptomics (ST). ST acts like a high-throughput molecular microscope to allow visualisation and quantitative analysis of the transcriptome with spatial resolution in individual tissue sections, affording near-single cell resolution. SpatialArth will generate new knowledge on the molecular profile of the osteochondral unit and will identify with spatial resolution which cells are involved in the pathogenesis of OA. I will combine ST sequencing and protein expression data from cartilage and bone tissues from OA patients (matched tissues from intact and degraded regions of tibial plateau) and tissues derived from non-OA knee joints. Additionally, I will develop my computational genomics skillset, aiming to help fill the need for a much-needed next generation of interdisciplinary researchers. SpatialArth addresses several mandatory European Union calls - finding strategies supporting healthy and active aging and decreasing the economic burden on healthcare.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2020

See all projects funded under this call

Coordinator

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Net EU contribution
€ 174 806,40
Address
INGOLSTADTER LANDSTRASSE 1
85764 Neuherberg
Germany
Region
Bayern Oberbayern München, Landkreis
Activity type
Research Organisations
Links
Total cost
€ 174 806,40